Healio: COBRA results published: Cryoplasty reduced restenosis rates in patients with diabetes Please provide your email address to receive an email when new articles are posted on . Results from the COBRA trial have indicated that cryoplasty using nitinol self-expanding stents significantly ... TCTMD: CryoPlasty® Therapy With Boston Scientific PolarCath™ Dilatation System Reduces Restenosis Rates by Nearly 50 Percent in Peripheral Stenting Procedures NATICK, Mass.
and SAN FRANCISCO, Boston Scientific Corporation welcomed positive outcomes from the COBRA clinical trial, which evaluated post-dilation of nitinol stents using CryoPlasty® Therapy with ... CryoPlasty® Therapy With Boston Scientific PolarCath™ Dilatation System Reduces Restenosis Rates by Nearly 50 Percent in Peripheral Stenting Procedures Medscape: Indications and Results with Cryoplasty in the Treatment of Infrainguinal Arterial Occlusive Disease Indications and Results with Cryoplasty in the Treatment of Infrainguinal Arterial Occlusive Disease TCTMD: In patients with diabetes, Cryoplasty post-dilation compared to conventional balloon angioplasty decreases the risk of in-stent restenosis In patients with diabetes, Cryoplasty post-dilation compared to conventional balloon angioplasty decreases the risk of in-stent restenosis of the Superficial Femoral Artery Results of the COBRA Trial ... In patients with diabetes, Cryoplasty post-dilation compared to conventional balloon angioplasty decreases the risk of in-stent restenosis (Phoenix) — Early results suggest that cryoplasty is an effective treatment for lower extremity in-stent restenosis (ISR), as evidenced by a 10-month post procedure patency rate of 78%, ... The region's first CryoPlasty, a new type of therapy for peripheral vascular disease (PVD), was performed at San Jacinto Methodist Hospital by interventional cardiologist Edward Leahey MD.
